Breaking News Instant updates and real-time market news.

VZ

Verizon

$48.41

-0.53 (-1.08%)

, TIME

Time Inc.

$18.60

0.05 (0.27%)

07:24
04/21/17
04/21
07:24
04/21/17
07:24

Verizon may be rumored company in Time sale, NY Post reports

Verizon (VZ) may be the the undisclosed public company mulling the Time (TIME) sale, the New York Post reports, citing stockholder comments. The company could add competition to the sale, which currently includes bids from Meredith (MDP) and a joint venture of Pamplona Capital and Najafi. Meredith, regarded as the lead suitor, "is believed to be trying to keep a price below $20 a share," according to the NY Post. Verizon, which owns AOL, is currently in the process of a $4.4B purchase of Yahoo (YHOO) expected to close in June. Reference Link

VZ

Verizon

$48.41

-0.53 (-1.08%)

TIME

Time Inc.

$18.60

0.05 (0.27%)

MDP

Meredith

$64.75

0.7 (1.09%)

YHOO

Tag AABA

$47.67

0.67 (1.43%)

  • 27

    Apr

  • 09

    May

VZ Verizon
$48.41

-0.53 (-1.08%)

04/20/17
BTIG
04/20/17
NO CHANGE
BTIG
Comcast should try 'hail mary' Charter acquisition, says BTIG
BTIG analyst Rich Greenfield makes the case that Comcast's (CMCSA) "window for M&A is simply to enticing too ignore" and lays out six potential targets that would "truly be transformative," with his top pick among the group being Charter (CHTR). A combination of Charter with Comcast would have "all of the benefits of the legacy Time Warner Cable deal with even more scale" and even though odds of approval are no better than 50/50, it is worth throwing that "hail-mary," Greenfield tells investors. The other five possible deals that Greenfield makes the case for are Disney (DIS), Verizon (VZ), Netflix (NFLX), T-Mobile (TMUS) and Snap Inc.'s (SNAP) Snapchat.
04/19/17
04/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ING Group (ING) initiated with a Buy at Jefferies. 2. T-Mobile (TMUS) was initiated with a Buy at SunTrust while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 3. DXC Technology (DXC) initiated with an Overweight at JPMorgan. 4. LendingClub (LC) coverage resumed with a Hold at Stifel. 5. Halliburton (HAL) and Schlumberger (SLB) were initiated with a Buy at HSBC while Baker Hughes (BHI) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/19/17
PACS
04/19/17
NO CHANGE
PACS
Zayo Group has negative read through from Verizon deal, says Pacific Crest
After Verizon (VZ) agreed to buy fiber from Corning (GLW), Pacific Crest analyst Brandon Nispel says the deal indicates that Verizon prefers to build a fiber network on its own instead of leasing one from a third party. The analyst views this development as negative for Zayo which is building and looking to lease fiber networks. He keeps a Sector Weight rating on the stock.
04/21/17
ARGS
04/21/17
DOWNGRADE
ARGS
Hold
Verizon downgraded to Hold from Buy at Argus
Argus analyst Joseph Bonner,downgraded Verizon based on the company's subscriber losses and "intense competition." He says that the company has been forced to offer "unsubsidized phone plans and unlimited data" which have hurt its results.
TIME Time Inc.
$18.60

0.05 (0.27%)

02/17/17
SPHN
02/17/17
DOWNGRADE
Target $15
SPHN
Underweight
Time Inc. downgraded to Underweight from Equal Weight at Stephens
Stephens analyst Kyle Evans downgraded Time Inc. to Underweight from Equal Weight and lowered his price target on the stock to $15 from $17, saying he sees low revenue visibility, limiting a potential buyout premium.
03/20/17
SPHN
03/20/17
UPGRADE
SPHN
Equal Weight
Time Inc. upgraded to Equal Weight from Underweight at Stephens
01/10/17
01/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Express (AXP) upgraded to Outperform from Perform at Oppenheimer with analyst Ben Chittenden citing a better economic backdrop and the stock's underperformance relative to peers since the U.S. election. 2. Barracuda (CUDA) was upgraded to Neutral from Underperform at DA Davidson and to Overweight from Equal Weight at Stephens. 3. Acuity Brands (AYI) was upgraded to Outperform from Neutral at Baird and to Buy from Outperform at CLSA. 4. E-Trade (ETFC) upgraded to Buy from Neutral at Goldman with analyst Conor Fitzgerald saying he expects revenue acceleration from higher rates combined with balance sheet growth from deposit sweeps, focus on expenses by new management, and potential for reduced bank regulation. 5. Time Inc. (TIME) upgraded to Outperform from Market Perform at Wells Fargo with analyst Eric Katz citing potential upside from a takeover by Meredith (MDP). A combination makes sense, and Meredith shares are pricing in a $23 purchase price for Time, Katz tells investors in a research note. Should a deal not materialize, Time shares could fall to $14, but it's more likely a deal is done at $23 per share, the analyst argues. Katz raised his price target range for Time to $21-$23 from $15-$17. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/17
WELS
01/10/17
UPGRADE
WELS
Outperform
Time Inc. upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Eric Katz upgraded Time Inc. (TIME) to Outperform citing potential upside from a takeover by Meredith (MDP). A combination makes sense, and Meredith shares are pricing in a $23 purchase price for Time, Katz tells investors in a research note. Should a deal not materialize, Time shares could fall to $14, but it's more likely a deal is done at $23 per share, the analyst argues. Katz raised his price target range for Time to $21-$23 from $15-$17.
MDP Meredith
$64.75

0.7 (1.09%)

01/26/17
BNCH
01/26/17
DOWNGRADE
Target $64
BNCH
Hold
Meredith downgraded to Hold from Buy at Benchmark
Benchmark analyst Daniel Kurnos downgraded Meredith to Hold from Buy citing the recent run-up in the stock and his belief that a strategic transaction is not imminent. While he still sees a transformative acquisition as the most likely outcome, he sees a challenging outlook for Meredith over the next 2 quarters, said Kurnos, who has a $64 price target on the stock.
01/06/17
SPHN
01/06/17
NO CHANGE
SPHN
Stephens bearish on hypothetical Meredith, Time Inc. deal
Following rumors that Meredith (MDP) is interested in merging with/acquiring Time Inc. (TIME), Stephens analyst Kyle Evans says he does not like the risk/reward of both companies merging. The analyst believes Time Inc. would add "significant operational risk" to Meredith's smaller, more-focused magazine business and risk investor confusion, while from a Time Inc. shareholder perspective, the timing is bad given recent/significant management and operational changes. Moreover, Evans believes the revenue and cost synergies of a combination are unclear. He reiterates an Equal Weight on both shares.
01/26/17
SPHN
01/26/17
NO CHANGE
Target $60
SPHN
Equal Weight
Meredith price target raised to $60 from $56 at Stephens
Stephens analyst Kyle Evans raised his price target for Meredith to $60 from $56 after the company posted a "solid" Q2 and reiterated 2017 guidance. The analyst reiterates an Equal Weight on the shares.
YHOO Tag AABA
$47.67

0.67 (1.43%)

01/05/17
RHCO
01/05/17
NO CHANGE
RHCO
Verizon likely to proceed with Yahoo acquisition, says SunTrust
After Bloomberg reported that Verizon (VZ) was seeking a $5.5B loan, SunTrust analyst Kunal Madhukar says that, assuming the report is accurate, the loan would probably be used to finance Verizon's takeover of Yahoo's (YHOO) core business. The analyst says that if the report is accurate, the deal will probably proceed. Madhukar keeps a Hold rating on Yahoo.
01/24/17
OPCO
01/24/17
NO CHANGE
Target $52
OPCO
Outperform
Yahoo sale will be completed despite hacking disclosure, says Oppenheimer
Following Q4 results, Oppenheimer analyst Jason Helfstein notes that Yahoo (YHOO) pushed back the closing of the core sale to Verizon (VZ) from Q1 to Q2, citing "work required to meet closing conditions." The analyst believes that the sale will be completed regardless of Yahoo's most recent hacking disclosure, as it provided engagement data showing minimal impact and since Verizon needs its content scale to create a profitable ad tech stack, if they are going to build a competitive "third stack" to help publishers compete with Facebook (FB) and Google (GOOG; GOOGL). He reiterated an Outperform on Yahoo's stock but lowered his price target on the shares to $52 from $54 to reflect movements in the share prices of Alibaba (BABA) and Yahoo Japan.
01/24/17
RBCM
01/24/17
NO CHANGE
RBCM
Yahoo results increase probability of deal closing, says RBC Capital
RBC Capital analyst Mark Mahaney says that Yahoo's (YHOO) "improved" Q4 results increase the chances that Verizon (VZ) will close on its acquisition of the Internet conglomerate. However, Mahaney keeps a Sector Perform rating on Yahoo.
04/19/17
OPCO
04/19/17
NO CHANGE
Target $57
OPCO
Outperform
Yahoo price target raised to $57 from $52 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Yahoo to $57 from $52 after the company reported Q1 earnings. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

MLHR

Herman Miller

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
Breaking Hot Stocks news story on Herman Miller »

Herman Miller reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

STBZ

State Bank Financial

$27.79

0.45 (1.65%)

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
FDIC approves State Bank Financial, AloStar merger transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Hot Stocks
Herman Miller CEO says 'encouraged by the strong level of demand' »

Brian Walker, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ARCC

Ares Capital

$15.85

0.035 (0.22%)

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Initiation
Ares Capital initiated  »

Ares Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:06
09/20/17
09/20
16:06
09/20/17
16:06
Earnings
Herman Miller sees Q2 EPS 55c-61c, consensus 56c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MLHR

Herman Miller

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Earnings
Herman Miller reports Q1 adjusted EPS 57c, consensus 57c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MDXG

MiMedx

$12.34

-0.82 (-6.23%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
MiMedx responds to two "deceptive short seller articles" »

MiMedx Group responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LUNA

Luna Innovations

$1.64

0.05 (3.14%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
Luna Innovations announces stock repurchase program »

Luna Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03
Hot Stocks
Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02% »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Feb

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

DMPI

DelMar Pharmaceuticals

$1.12

0.0294 (2.70%)

15:33
09/20/17
09/20
15:33
09/20/17
15:33
Syndicate
DelMar Pharmaceuticals announces $10M registered direct offering at-the-market »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$47.94

0.27 (0.57%)

15:30
09/20/17
09/20
15:30
09/20/17
15:30
Options
Far downside put buying in Morgan Stanley »

Far downside put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 22

    Oct

JWN

Nordstrom

$46.13

-0.09 (-0.19%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Conference/Events
Nordstrom management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$71.38

-1.1 (-1.52%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Options
Bunge call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:25
09/20/17
09/20
15:25
09/20/17
15:25
General news
More from Yellen on inflation »

More from Yellen on…

WFC

Wells Fargo

$53.95

0.591 (1.11%)

15:22
09/20/17
09/20
15:22
09/20/17
15:22
Hot Stocks
Chair Yellen calls Wells Fargo actions 'unacceptable' »

Fed Chair Janet Yellen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 12

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

15:20
09/20/17
09/20
15:20
09/20/17
15:20
General news
The FOMC dot-plot projections »

The FOMC dot-plot…

$NSD

NASDAQ Market Internals

15:17
09/20/17
09/20
15:17
09/20/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

$NYE

NYSE Market Internals

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$170.00

4.17 (2.51%)

15:14
09/20/17
09/20
15:14
09/20/17
15:14
Conference/Events
Lennox management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.